Quvium

  • Home
  • About
    • Team
    • Board of Directors
    • Clinical Advisory Board
    • Investor Opportunities
    • Health Care Professionals >
      • Overview
      • Clinical Studies
  • Respiratory Conditions
  • Our Solution
  • Testimonials
  • Contact Us
  • News and Blog
  • Privacy Policy
  • Home
  • About
    • Team
    • Board of Directors
    • Clinical Advisory Board
    • Investor Opportunities
    • Health Care Professionals >
      • Overview
      • Clinical Studies
  • Respiratory Conditions
  • Our Solution
  • Testimonials
  • Contact Us
  • News and Blog
  • Privacy Policy

Quvium’s cough monitor boosts compliance by involving caregivers - says our CEO Steve Schmidt

5/24/2017

0 Comments

 
Picture
Thank you to  Sarah Faulkner, writer for DrugDeliveryNow and her piece this week following our CEO's, presentation at the recent Medical Sensors Design Conference this month.

Steve (our CEO) talked about Eric Olson, the man who led the development of the 1st drug to treat the underlying causes of cystic fibrosis, and how he'd asked him to look into ways that families could become more engaged with managing a patient’s condition. Olson pointed towards a publication that showed that involving caregivers added 8 years of life expectancy to children with cystic fibrosis.

This has led Steve to the creation of SONASURE
 of a wearable cough monitor that alerts patients’ care community when a cough is out of the ordinary, so they can intervene before an attack or flare up.

​For the full story, please go to:
http://www.drugdeliverybusiness.com/quviums-cough-monitor-boosts-compliance-involving-caregivers/


0 Comments



Leave a Reply.

    Categories

    All

Address
Discovery Park
Ramsgate Road
Sandwich
Kent CT13 9ND

Contact Us 
Email - info@quvium.com
​
Telephone - 01304 802717

Find Us On